BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12234375)

  • 1. Protein kinase ERK contributes to differential responsiveness of human myeloma cell lines to IFNalpha.
    Song L; Li Y; Shen B
    Cancer Cell Int; 2002 Jul; 2(1):9. PubMed ID: 12234375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the biological activity and molecular mechanism of IFNalpha on human myeloma cell line Sko-007].
    Song L; Li Y; Sun Y; Shen B
    Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):517-9. PubMed ID: 12482347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of IL-6 signal transduction pathway in a human multiple myeloma cell line--Sko-007].
    Song L; Li Y; Shen B
    Zhonghua Xue Ye Xue Za Zhi; 2000 Nov; 21(11):569-71. PubMed ID: 11225245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoinositide 3-kinase regulates a subset of interferon-alpha-stimulated genes.
    Hjortsberg L; Lindvall C; Corcoran M; Arulampalam V; Chan D; Thyrell L; Nordenskjold M; Grandér D; Pokrovskaja K
    Exp Cell Res; 2007 Jan; 313(2):404-14. PubMed ID: 17141757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.
    Thyrell L; Arulampalam V; Hjortsberg L; Farnebo M; Grandér D; Pokrovskaja Tamm K
    Exp Cell Res; 2007 Nov; 313(19):4015-24. PubMed ID: 17880940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells.
    Pedranzini L; Dechow T; Berishaj M; Comenzo R; Zhou P; Azare J; Bornmann W; Bromberg J
    Cancer Res; 2006 Oct; 66(19):9714-21. PubMed ID: 17018630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression.
    Jelinek DF; Aagaard-Tillery KM; Arendt BK; Arora T; Tschumper RC; Westendorf JJ
    J Clin Invest; 1997 Feb; 99(3):447-56. PubMed ID: 9022078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association and contribution of ERK to IL-6-induced activation of signal transducer and activator of transcription in a human myeloma cell line.
    Song L; Shen B; Li Y
    Chin Med J (Engl); 2001 Sep; 114(9):954-7. PubMed ID: 11780390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activation of PKA pathway inhibits reactivity of human myeloma cell line-U266 to IL-6].
    Song J; Li Y; Shen B
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):278-80. PubMed ID: 11783106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-interferon and its effects on signalling pathways within cells.
    Caraglia M; Vitale G; Marra M; Budillon A; Tagliaferri P; Abbruzzese A
    Curr Protein Pept Sci; 2004 Dec; 5(6):475-85. PubMed ID: 15581417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 inhibits apoptosis of human myeloma cell line XG-7 through activation of JAK/STAT pathway and up-regulation of Mcl-1.
    Song L; Li Y; Sun YX; Yu M; Shen BF
    Ai Zheng; 2002 Feb; 21(2):113-6. PubMed ID: 12479056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.
    Zheng X; Li AS; Zheng H; Zhao D; Guan D; Zou H
    PLoS One; 2015; 10(3):e0119780. PubMed ID: 25781885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
    Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC
    Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-interferon and its effects on signal transduction pathways.
    Caraglia M; Marra M; Pelaia G; Maselli R; Caputi M; Marsico SA; Abbruzzese A
    J Cell Physiol; 2005 Feb; 202(2):323-35. PubMed ID: 15389589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells.
    Noser JA; Mael AA; Sakuma R; Ohmine S; Marcato P; Lee PW; Ikeda Y
    Mol Ther; 2007 Aug; 15(8):1531-6. PubMed ID: 17505473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of STAT1 is required for interferon-alpha-mediated cell death.
    Arulampalam V; Kolosenko I; Hjortsberg L; Björklund AC; Grandér D; Tamm KP
    Exp Cell Res; 2011 Jan; 317(1):9-19. PubMed ID: 20937272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
    Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
    J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 up-regulates mcl-1 in human myeloma cells through JAK / STAT rather than ras / MAP kinase pathway.
    Puthier D; Bataille R; Amiot M
    Eur J Immunol; 1999 Dec; 29(12):3945-50. PubMed ID: 10602002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells.
    Ogata A; Chauhan D; Urashima M; Teoh G; Treon SP; Anderson KC
    Clin Cancer Res; 1997 Jun; 3(6):1017-22. PubMed ID: 9815779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells.
    Liu S; Ma Z; Cai H; Li Q; Rong W; Kawano M
    Eur J Haematol; 2010 Feb; 84(2):137-44. PubMed ID: 19878271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.